Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-11 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-11 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-11 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.25 | 3e-11 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.25 | 5e-11 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.26 | 6e-11 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.25 | 7e-11 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.26 | 8e-11 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.25 | 8e-11 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-10 |